Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Clinical trial NCT06350318 · RECRUITING
Trial details
- NCT number
- NCT06350318
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2029-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.